The first stop for professional medicines advice

Guidance

1,287 results

Applied filters

Using angiotensin-II receptor antagonists during breastfeeding

11 May 2023Very limited data suggest breastmilk levels are likely to be low, but other medicine classes are preferred. Recommendations apply to full term, healthy infants.

PGD Learning Event 2: An update on what's new in PGDs

10 May 2023An update session for those managing and using PGDs and other medicine mechanisms in practice

Dealing with out of specification (OOS) results: Part 2

9 May 2023This webinar builds on the principles described in Part 1 of this series and describes how to conduct a thorough and systematic microbiological investigation.

Understanding Patient Group Directions and Integrated Care Boards

3 May 2023We outline the responsibilities of ICBs in England as commissioners of NHS services using PGDs, and link to resources that provide further support and advice.

Using lipid-lowering medicines during breastfeeding

21 April 2023Rosuvastatin, pravastatin and atorvastatin are preferred; simvastatin and ezetimibe can also be used. Recommendations apply to full term and healthy infants.

Omeprazole for use within antenatal and maternity services

20 April 2023SPS protocol templates for the supply and administration of omeprazole for pre planned caesarean section by registered midwives.

Legally providing General Sales List and Pharmacy Only medicines by registered midwives

20 April 2023Advice to support registered midwives in the legal administration and/or supply of P and GSL medicine, using omeprazole tablets as an example.

PGD Learning Event 1: New to PGDs

18 April 2023This learning event covered the background to PGDs and medicines mechanisms, and their use in practice.

Submitting iQAAPS Quality Indicators (QIs)

13 April 2023Guidance for Accountable Pharmacists on submission of Quality Indicators (QI) for NHS Section 10 aseptic preparation activities using the iQAAPS system.

Using bisphosphonates with proton pump inhibitors (PPIs)

4 April 2023Although no interaction between bisphosphonates and PPIs is documented, the increased risk of fractures when given together should be reviewed and managed